YourChoice Therapeutics Direct Investment Page

YourChoice Therapeutics develops non-hormonal contraceptives designed to eliminate the risk of negative side effects associated with traditional hormonal contraceptives. The company's contraceptives work by blocking a protein in sperm required for fertilization, enabling customers to use safe birth control options with no side effects for men and women.


Portfolio Company | In the News

YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill

June 03, 2024

YourChoice Therapeutics Advances Hormone-Free Male Birth Control Pill to Second Human Study

FemTech Insider

October 1, 2024


Fund Performance Overview

Quarterly Reports

The highlights of Q3 2024 updates as provided by the company. Please note all updates provided are confidential and not for distribution. To access the file, use password: Q324YCSPV!


Videos

Company Update and performance overview from YourChoice


Leadership Team